Imagen Biotech is located at the Manchester Bioscience Incubator in the UK, a state-of-the-art biotechnology research and development centre combining the latest in laboratory facilities.
Imagen Biotech is the only dedicated High Content Biology company in the UK. Like our namesake Imogen, we are the image of our parent in that we were born out of a major pharmaceutical company. Therefore, we understand the unique data requirements of the industry to rapidly determine the potency, efficacy and mode of action of a compound series within a cellular context.
We service both industry and academia offering great High Content Screening assays including our own unique fixed apoptosis assay. We also support industry by offering an outsourcing alternative to complement their own internal R&D. Imagen Biotech has been set up by former industry experts in High Content and Systems Biology. Both founders have worked in academia and industry so we are ideally placed to provide a great High Content Screening and assay development service for our customers.
